Metabolic flux balance analysis during lactate and glucose concomitant consumption in HEK293 cell cultures
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
At early stages of the exponential growth phase in HEK293 cell cultures, the tricarboxylic acid cycle is unable to process all the amount of NADH generated in the glycolysis pathway, being lactate the main by‐product. However, HEK293 cells are also able to metabolize lactate depending on the environmental conditions. It has been recently observed that one of the most important modes of lactate metabolization is the cometabolism of lactate and glucose, observed even during the exponential growth phase. Extracellular lactate concentration and pH appear to be the key factors triggering the metabolic shift from glucose consumption and lactate production to lactate and glucose concomitant consumption. The hypothesis proposed for triggering this metabolic shift to lactate and glucose concomitant consumption is that HEK293 cells metabolize extracellular lactate as a response to both extracellular protons and lactate accumulation, by means of cotransporting them (extracellular protons and lactate) into the cytosol. At this point, there exists a considerable controversy about how lactate reaches the mitochondrial matrix: the first hypothesis proposes that lactate is converted into pyruvate in the cytosol, and afterward, pyruvate enters into the mitochondria; the second alternative considers that lactate enters first into the mitochondria, and then, is converted into pyruvate. In this study, lactate transport and metabolization into mitochondria is shown to be feasible, as evidenced by means of respirometry tests with isolated active mitochondria, including the depletion of lactate concentration of the respirometry assay. Although the capability of lactate metabolization by isolated mitochondria is demonstrated, the possibility of lactate being converted into pyruvate in the cytosol cannot be excluded from the discussion. For this reason, the calculation of the metabolic fluxes for an HEK293 cell line was performed for the different metabolic phases observed in batch cultures under pH controlled and noncontrolled conditions, considering both hypotheses. The main objective of this study is to evaluate the redistribution of cellular metabolism and compare the differences or similarities between the phases before and after the metabolic shift of HEK293 cells (shift observed when pH is not controlled). That is from a glucose consumption/lactate production phase to a glucose‐lactate coconsumption phase. Interestingly, switching to a glucose and lactate cometabolization results in a better‐balanced cell metabolism, with decreased glucose and amino acids uptake rates, affecting minimally cell growth. This behavior could be applied to further develop new approaches in terms of cell engineering and to develop improved cell culture strategies in the field of animal cell technology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
On the origin of mitosing cells
Sagan, L. (1967) · Journal of Theoretical Biology · doi:10.1016/0022-5193(67)90079-3 · Cited by 1,870
The effects of alternate optimal solutions in constraint-based genome-scale metabolic models
Mahadevan, R., & Schilling, C. H. (2003) · Metabolic Engineering · doi:10.1016/j.ymben.2003.09.002 · Cited by 1,203 · cited 1×
“Metabolic flux ranges were determined by flux variability analysis (FVA; Mahadevan & Schilling, 2003), as implemented in Opflux, constraining a minimum flux for the objective function (R_DM_ATP_c) of 95%.”
MethodHigh-throughput generation, optimization and analysis of genome-scale metabolic models
Henry, C. S., DeJongh, M., Best, A. A., Frybarger, P. M., Linsay, B., & Stevens, R. L. (2010) · Nature Biotechnology · doi:10.1038/nbt.1672 · Cited by 1,090
A community-driven global reconstruction of human metabolism
Thiele, I., Swainston, N., Fleming, R. M. T., Hoppe, A., Sahoo, S., Aurich, M. K., Haraldsdottir, H., Mo, M. L., Rolfsson, O., Stobbe, M. D., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2488 · Cited by 1,019 · cited 1×
“0 (Thiele et al., 2013) model for HEK293 cells.”
Human cell lines for biopharmaceutical manufacturing: history, status, and future perspectives
Dumont, J., Euwart, D., Mei, B., Estes, S., & Kshirsagar, R. (2016) · Critical Reviews in Biotechnology · doi:10.3109/07388551.2015.1084266 · Cited by 483
Metabolic flux and the regulation of mammalian cell growth
Locasale, J. W., & Cantley, L. C. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.07.014 · Cited by 449 · cited 1×
“Consequently, NADH regeneration has to be done in the cytoplasm, with the concomitant production of high amounts of lactate that is eventually secreted to the culture broth (Locasale & Cantley, 2011; Mulukutla, Gramer, & Hu, 2012).”
BackgroundExpression systems for therapeutic glycoprotein production
Durocher, Y., & Butler, M. (2009) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2009.10.008 · Cited by 386 · cited 1×
“…expression for gene therapy (Delenda, Chillon, Douar, & Merten, 2007; Liste‐Calleja, Lecina, & Cairó, 2014; Somia & Verma, 2000) to protein expression (Dumont, Euwart, Mei, Estes, & Kshirsagar, 2016; Román et al., 2016), in which human glycosylation patterns are needed (Durocher & Butler, 2009).”
Effects of ammonia and lactate on hybridoma growth, metabolism, and antibody production
Ozturk, S. S., Riley, M. R., & Palsson, B. O. (1992) · Biotechnology and Bioengineering · doi:10.1002/bit.260390408 · Cited by 370
San Martín, A., Ceballo, S., Ruminot, I., Lerchundi, R., Frommer, W. B., & Barros, L. F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057712 · Cited by 361
Recon 2.2: from reconstruction to model of human metabolism
Swainston, N., Smallbone, K., Hefzi, H., Dobson, P. D., Brewer, J., Hanscho, M., Zielinski, D. C., Ang, K. S., Gardiner, N. J., Gutierrez, J. M., et al. (2016) · Metabolomics · doi:10.1007/s11306-016-1051-4 · Cited by 285 · cited 1×
“2 (Swainston et al., 2016).”
Pereira, S., Kildegaard, H. F., & Andersen, M. R. (2018) · Biotechnology Journal · doi:10.1002/biot.201700499 · Cited by 214
Hashimoto, T., Hussien, R., Cho, H.-S., Kaufer, D., & Brooks, G. A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002915 · Cited by 196
Mechanisms driving the lactate switch in Chinese hamster ovary cells
Hartley, F., Walker, T., Chung, V., & Morten, K. (2018) · Biotechnology and Bioengineering · doi:10.1002/bit.26603 · Cited by 108
Elevated pCO2 affects the lactate metabolic shift in CHO cell culture processes
Brunner, M., Doppler, P., Klein, T., Herwig, C., & Fricke, J. (2018) · Engineering in Life Sciences · doi:10.1002/elsc.201700131 · Cited by 63
Cited by
Process modeling of recombinant adeno-associated virus production in HEK293 cells
Joiner, J., Huang, Z., McHugh, K., Stebbins, M., Aron, K., Borys, M., & Khetan, A. (2022) · Current Opinion in Chemical Engineering · doi:10.1016/j.coche.2022.100823 · Cited by 17
Gurazada, S. G. R., Kennedy, H. M., Braatz, R. D., Mehrman, S. J., Polson, S. W., & Rombel, I. T. (2025) · Biotechnology Advances · doi:10.1016/j.biotechadv.2024.108506 · Cited by 9
Patulin Alters Insulin Signaling and Metabolic Flexibility in HepG2 and HEK293 Cells
Pillay, Y., Nagiah, S., & Chuturgoon, A. (2023) · Toxins · doi:10.3390/toxins15040244 · Cited by 6
“HEK293 cells are established from primary human embryonic kidney and have the capacity to switch metabolic processes from glucose consumption and lactate production to glucose–lactate co-consumption [43].”
Background
Metadata
- Authors
- Martínez‐Monge, I., Albiol, J., Lecina, M., Liste‐Calleja, L., Miret, J., Solà, C., & Cairó, J. J.
- Venue
- Biotechnology and Bioengineering
- Publisher
- Wiley
- Published
- 2018-12
- Volume
- 116
- Issue
- 2
- Pages
- 388-404
- ISSN
- 0006-3592 (ISSN-L)
- 1097-0290
- OpenAlex
- W2900437236
- Cited by
- 48
- References
- 14
- FWCI
- 1.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.